The legal implications of detecting Alzheimer's disease earlier

Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, Francis X Shen

Research output: Contribution to journalArticle

Abstract

Early detection of Alzheimer's disease (AD) raises a number of challenging legal questions. In this essay, we explore some of those questions, such as: Is a neurological indicator of increased risk for AD a legally relevant brain state before there are any outward behavioral manifestations? How should courts address evidentiary challenges to the admissibility of AD-related neuroimaging? How should the government regulate the marketing of neuroimaging diagnostic tools? How should insurance coverage for the use of these new tools be optimized? We suggest that many voices and multidisciplinary perspectives are needed to answer these questions and ensure that legal responses are swift, efficient, and equitable.

Original languageEnglish (US)
Pages (from-to)1207-1217
Number of pages11
JournalAMA Journal of Ethics
Volume18
Issue number12
DOIs
StatePublished - Dec 2016

Fingerprint Dive into the research topics of 'The legal implications of detecting Alzheimer's disease earlier'. Together they form a unique fingerprint.

Cite this